Clincosm LogoSign in Get a demo

metastatic clear cell renal cell carcinoma

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 18, 2023

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +11 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 5, 2022

Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (Nivolumab, SAbR)

Terminated
Has Results
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 12, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +2 more
  • Nivolumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
Mar 18, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2022

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial in United

Recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cytoreductive Nephrectomy
  • Active Comparator
  • Birmingham, Alabama
  • +223 more
Nov 8, 2021

Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (IL-2, Stereotactic Ablative Body Radiation Therapy)

Completed
Has Results
  • Metastatic Clear Cell Renal Cell Carcinoma
  • IL-2
  • Stereotactic Ablative Body Radiation Therapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 28, 2021

Metastatic Clear Cell Renal Cell Carcinoma Trial in United States (LY2510924, Sunitinib)

Terminated
Has Results
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +20 more
Jun 28, 2019

or Resistance to Targeted Therapies in Metastatic Clear Cell

Completed
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Rennes, France
    CHU de Rennes
Jul 27, 2016

Metastatic Clear Cell Renal Cell Carcinoma Trial in Nijmegen (Lu-177-DOTA-girentuximab)

Completed
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Aug 12, 2015